Increased expression of the Th17-IL-6R/pSTAT3/BATF/RorγT-axis in the tumoural region of adenocarcinoma as compared to squamous cell carcinoma of the lung

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Balabko, Ljubov ^a   Andreev, Katerina ^a   Burmann, Nadine ^a   Schubert, Melanie ^a   Mathews, Martina ^a   Trufa, Denis I ^a   Reppert, Sarah ^a   Rau, Tilmann ^a   Schicht, Martin ^a   Sirbu, Horia ^a   Hartmann, Arndt ^a   Finotto, Susetta ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; BATF PROTEIN, HUMAN; BATF PROTEIN, MOUSE; IL6R PROTEIN, HUMAN; INTERLEUKIN 6 RECEPTOR; RETINOID RELATED ORPHAN RECEPTOR GAMMA; RORC PROTEIN, HUMAN; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN; STAT3 PROTEIN, MOUSE; TUMOR PROTEIN;

ADENOCARCINOMA; ADULT; AGED; ANIMAL; CLINICAL TRIAL; COMPARATIVE STUDY; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOLOGY; LUNG TUMOR; MALE; MIDDLE AGED; MOUSE; PATHOLOGY; REGULATORY T LYMPHOCYTE; SQUAMOUS CELL CARCINOMA; TH17 CELL; TUMOR CELL LINE; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MICE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASMS, EXPERIMENTAL; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; RECEPTORS, INTERLEUKIN-6; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84941875276     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep07396     Document Type: Article

References (18)

1. Aberle, D. R. et al. Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med 369, 920-931, doi:10.1056/NEJMoa1208962 (2013).
2. Maus, M. K. et al. KRAS mutations in non-small-cell lung cancer and colorectal cancer: Implications for EGFR-targeted therapies. Lung cancer, doi: 10.1016/j.lungcan.2013.11.010 (2013).
3. Kang, H. J. et al. Comparison of clinical characteristics between patients with ALK-positive and EGFR-positive lung adenocarcinoma. Respir Med, doi:10.1016/j.rmed.2013.11.020 (2013).
4. Song, L., Rawal, B., Nemeth, J. A. & Haura, E. B. JAK1 activates STAT3 activity in non-small-cell lung cancer cells and IL-6 neutralizing antibodies can suppress JAK1-STAT3 signaling. MCT 10, 481-494, doi:10.1158/1535-7163. MCT-10-0502 (2011).
5. Andreev, K., Graser, A., Maier, A., Mousset, S. & Finotto, S. Therapeutical measures to control airway tolerance in asthma and lung cancer. Front Immunol 3, 216, doi:10.3389/fimmu.2012.00216 (2012).
6. Acosta-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A. & Sallusto, F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 8, 942-949, doi:10.1038/ni1496 (2007).
7. Senga, T. et al. Stat3-dependent induction of BATF in M1 mouse myeloid leukemia cells. Oncogene 21, 8186-8191, doi:10.1038/sj.onc.1205918 (2002).
8. Liu, X., Lee, Y. S., Yu, C. R. & Egwuagu, C. E. Loss of STAT3 in CD41 T cells prevents development of experimental autoimmune diseases. J Immunol 180, 6070-6076 (2008).
9. Yang, X. O. et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 282, 9358-9363, doi:10.1074/jbc. C600321200 (2007).
10. Hirahara, K. et al. Signal transduction pathways and transcriptional regulation in Th17 cell differentiation. Cytokine Growth Factor Rev 21, 425-434, doi:10.1016/j.cytogfr.2010.10.006 (2010).
11. Liao, J., Humphrey, S. E., Poston, S. & Taparowsky, E. J. Batf promotes growth arrest and terminal differentiation of mouse myeloid leukemia cells. MCR 9, 350-363, doi:10.1158/1541-7786. MCR-10-0375 (2011).
12. Yu, H., Pardoll, D. & Jove, R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9, 798-809, doi:10.1038/nrc2734 (2009).
13. Koch, S. et al. IL-6 activated integrated BATF/IRF4 functions in lymphocytes are T-bet-independent and reversed by subcutaneous immunotherapy. SciRep 3, 1754, doi:10.1038/srep01754 (2013).
14. Doganci, A. et al. The IL-6R alpha chain controls lung CD41CD251 Treg development and function during allergic airway inflammation in vivo. J Clin Invest 115, 313-325, doi:10.1172/JCI22433 (2005).
15. Ubel, C. et al. The activating protein 1 transcription factor basic leucine zipper transcription factor, ATF-like (BATF), regulates lymphocyte- and mast celldriven immune responses in the setting of allergic asthma. J Allergy Clin Immunol 133, 198-206 e191-199, doi:10.1016/j.jaci.2013.09.049 (2014).
16. Li, P. et al. BATF-JUN is critical for IRF4-mediated transcription in T cells. Nature 490, 543-546, doi:10.1038/nature11530 (2012).
17. Burchill, M. A., Yang, J., Vang, K. B. & Farrar, M. A. Interleukin-2 receptor signaling in regulatory T cell development and homeostasis. Immunol Lett 114, 1-8, doi:10.1016/j.imlet.2007.08.005 (2007).
18. Sauer, K. A., Scholtes, P., Karwot, R. & Finotto, S. Isolation of CD41 T cells from murine lungs: a method to analyze ongoing immune responses in the lung. Nat Protoc 1, 2870-2875, doi:10.1038/nprot.2006.435 (2006).